Who wants government health care and unemployment programs to expand? Who wants government health care and unemployment programs to expand? A study by Penn LDI fellows finds that people who felt most at risk from COVID-19 tend to favor expansions, regardless of their political attitudes.
Behind the scenes in the lab and the future of mRNA research Behind the scenes in the lab and the future of mRNA research Developing new vaccines and novel mRNA delivery methods, coupled with the satisfaction of mentoring and selfless dedication to medicine, inspire the work of scientists at the Weissman Lab.
It’s not true that nearly half of pregnant women in Pfizer’s COVID-19 vaccine trial miscarried Penn In the News Politifact It’s not true that nearly half of pregnant women in Pfizer’s COVID-19 vaccine trial miscarried An analysis by Jeffrey Morris of the Perelman School of Medicine disproved a Facebook post claiming a 44% miscarriage rate among pregnant women in Pfizer’s COVID vaccine trial. A simple rule for planning your fall booster shot Penn In the News The Atlantic A simple rule for planning your fall booster shot Med student Rishi Goel of the Perelman School for Medicine says that the new bivalent vaccines will have some benefit for almost everyone who receives them. Tweaked COVID boosters close but how much will they help? Penn In the News Associated Press Tweaked COVID boosters close but how much will they help? E. John Wherry of the Perelman School of Medicine compares vaccine tweaks to periodic software updates and advises waiting four to six months between boosters. Variant-targeted COVID-19 boosters test the promise of mRNA technology Penn In the News The Wall Street Journal Variant-targeted COVID-19 boosters test the promise of mRNA technology Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus. What's behind the FDA’s controversial strategy for evaluating new COVID boosters Penn In the News NPR What's behind the FDA’s controversial strategy for evaluating new COVID boosters Paul Offit of the Perelman School of Medicine says that the FDA needs solid data to ensure that the new BA.4/5 boosters have a dramatically greater neutralizing antibody response. Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza. Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks. How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva. Load More
A simple rule for planning your fall booster shot Penn In the News The Atlantic A simple rule for planning your fall booster shot Med student Rishi Goel of the Perelman School for Medicine says that the new bivalent vaccines will have some benefit for almost everyone who receives them. Tweaked COVID boosters close but how much will they help? Penn In the News Associated Press Tweaked COVID boosters close but how much will they help? E. John Wherry of the Perelman School of Medicine compares vaccine tweaks to periodic software updates and advises waiting four to six months between boosters. Variant-targeted COVID-19 boosters test the promise of mRNA technology Penn In the News The Wall Street Journal Variant-targeted COVID-19 boosters test the promise of mRNA technology Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus. What's behind the FDA’s controversial strategy for evaluating new COVID boosters Penn In the News NPR What's behind the FDA’s controversial strategy for evaluating new COVID boosters Paul Offit of the Perelman School of Medicine says that the FDA needs solid data to ensure that the new BA.4/5 boosters have a dramatically greater neutralizing antibody response. Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza. Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks. How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva. Load More
Tweaked COVID boosters close but how much will they help? Penn In the News Associated Press Tweaked COVID boosters close but how much will they help? E. John Wherry of the Perelman School of Medicine compares vaccine tweaks to periodic software updates and advises waiting four to six months between boosters. Variant-targeted COVID-19 boosters test the promise of mRNA technology Penn In the News The Wall Street Journal Variant-targeted COVID-19 boosters test the promise of mRNA technology Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus. What's behind the FDA’s controversial strategy for evaluating new COVID boosters Penn In the News NPR What's behind the FDA’s controversial strategy for evaluating new COVID boosters Paul Offit of the Perelman School of Medicine says that the FDA needs solid data to ensure that the new BA.4/5 boosters have a dramatically greater neutralizing antibody response. Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza. Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks. How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva. Load More
Variant-targeted COVID-19 boosters test the promise of mRNA technology Penn In the News The Wall Street Journal Variant-targeted COVID-19 boosters test the promise of mRNA technology Drew Weissman of the Perelman School of Medicine, whose key discoveries about mRNA contributed to Moderna and BioNTech, says that mRNA is designed to rapidly adapt to new strains and variants of virus. What's behind the FDA’s controversial strategy for evaluating new COVID boosters Penn In the News NPR What's behind the FDA’s controversial strategy for evaluating new COVID boosters Paul Offit of the Perelman School of Medicine says that the FDA needs solid data to ensure that the new BA.4/5 boosters have a dramatically greater neutralizing antibody response. Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza. Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks. How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva. Load More
What's behind the FDA’s controversial strategy for evaluating new COVID boosters Penn In the News NPR What's behind the FDA’s controversial strategy for evaluating new COVID boosters Paul Offit of the Perelman School of Medicine says that the FDA needs solid data to ensure that the new BA.4/5 boosters have a dramatically greater neutralizing antibody response. Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza. Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks. How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva. Load More
Severe COVID-19 increases risk of life-threatening blood clots Severe COVID-19 increases risk of life-threatening blood clots A new Penn study finds the clotting condition, venous thromboembolism, was more common in those hospitalized with COVID-19 compared to those hospitalized with influenza.
Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ Despite awareness of COVID-19 risks, many Americans say they’re back to ‘normal’ According to a national survey data from the Annenberg Public Policy Center, many in the U.S. are living “pre-pandemic” lifestyles, despite the continuing risks.
How a new chewing gum could ‘trap’ COVID-19, reduce spread: study Penn In the News New York Post How a new chewing gum could ‘trap’ COVID-19, reduce spread: study A study led by Henry Daniell of the School of Dental Medicine discovered that gum containing plant-grown protein could neutralize COVID particles in saliva.